Properties and use of H-series compounds as protein kinase inhibitors.
Hidaka
H
H
Watanabe
M
M
Kobayashi
R
R
D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / Q000031:analogs & derivatives; D000818:Animals; D017871:Calcium-Calmodulin-Dependent Protein Kinases; D047388:Casein Kinases; D007546:Isoquinolines / Q000494:pharmacology*; D007700:Kinetics; D016716:PC12 Cells; D010879:Piperazines / Q000494:pharmacology*; D011485:Protein Binding; D047428:Protein Kinase Inhibitors; D011494:Protein Kinases / Q000302:isolation & purification; D013449:Sulfonamides
D007546:Isoquinolines; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D013449:Sulfonamides; C058815:N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide; C063302:KN 62; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D011494:Protein Kinases; D047388:Casein Kinases; D017871:Calcium-Calmodulin-Dependent Protein Kinases; C063509:N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide